Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Abacus Life ( (ABL) ) has shared an update.
On December 19, 2025, Abacus Global Management, Inc. (Abacus Life) decided to voluntarily transfer the listings of its common stock and its 9.875% Fixed Rate Senior Notes due 2028 from the Nasdaq Stock Market to the New York Stock Exchange. Trading of both securities on Nasdaq ended at the close of the December 29, 2025 session, and trading on the NYSE was scheduled to begin at the market open on December 30, 2025, with the common stock to trade under the symbol “ABX” and the 2028 notes under “ABXL,” marking a significant change in the company’s trading venue and potentially its investor visibility.
The most recent analyst rating on (ABL) stock is a Buy with a $11.00 price target. To see the full list of analyst forecasts on Abacus Life stock, see the ABL Stock Forecast page.
Spark’s Take on ABL Stock
According to Spark, TipRanks’ AI Analyst, ABL is a Neutral.
Abacus Life’s overall stock score is driven by strong earnings call performance and positive technical indicators, despite challenges in valuation and financial performance. The company’s strategic initiatives and revenue growth are significant positives, but high P/E ratio and cash flow issues warrant caution.
To see Spark’s full report on ABL stock, click here.
More about Abacus Life
Abacus Global Management, Inc., which does business as Abacus Life, operates in the financial services sector and is publicly traded through its common stock and 9.875% Fixed Rate Senior Notes due 2028.
Average Trading Volume: 737,181
Technical Sentiment Signal: Buy
Current Market Cap: $830.9M
For a thorough assessment of ABL stock, go to TipRanks’ Stock Analysis page.